RecruitingPhase 3NCT07662109
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Dallas, TX · McKinney, TX · Paris, TX · +37 more sites